Literature DB >> 20080373

Precision in affinity capillary electrophoresis for drug-protein binding studies.

Deia El-Hady1, Sascha Kühne, Nagwa El-Maali, Hermann Wätzig.   

Abstract

In order to achieve excellent precision in the estimation of binding constants by affinity capillary electrophoresis (ACE), electroosmotic flow (EOF) stability is the key parameter, especially when using proteins in binding assays. Appropriate rinsing protocols are mandatory. In our study, the capillary was rinsed after each run with 0.1 mol/L sodium hydroxide for 2.0 min, with water for 2.0 min followed by running electrolyte (phosphate buffer at pH 7.4) for 3.0 min (pressure=3000 mbar each). Tryptophan-human serum albumin, warfarin-bovine serum albumin and quercetin-beta-lactoglobulin were used as ACE models. Further improvements in precision have been obtained by avoiding a complete standstill of liquid within the capillary and flushing the capillary with buffer for 25 min after each 30 consecutive runs. The precision of measurements is further improved by the use of mobility ratios to report mobility changes (RSD% less than 0.5% in a long-term measurement, n=300-600). Apart from the importance of a stable EOF, other ACE key parameters include protein concentration, drug plug length, applied voltage, and the choice of the regression method. In the present work, useful protocols and templates are provided in order to allow users a quick and efficient start with ACE methods. The comprehensive experimental part can serve as a checklist, which parameters need to be addressed for successfully applying ACE. Here, the suggested experimental design allows for the determination of binding constants within a couple of hours using standard instrumentation. This time could still be decreased by orders of magnitude using capillary arrays or miniaturized systems. Copyright (c) 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20080373     DOI: 10.1016/j.jpba.2009.12.022

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  6 in total

1.  A fluorescence-based high throughput assay for the determination of small molecule-human serum albumin protein binding.

Authors:  Megan M McCallum; Alan J Pawlak; William R Shadrick; Anton Simeonov; Ajit Jadhav; Adam Yasgar; David J Maloney; Leggy A Arnold
Journal:  Anal Bioanal Chem       Date:  2014-01-05       Impact factor: 4.142

2.  Use of peak decay analysis and affinity microcolumns containing silica monoliths for rapid determination of drug-protein dissociation rates.

Authors:  Michelle J Yoo; David S Hage
Journal:  J Chromatogr A       Date:  2010-10-16       Impact factor: 4.759

Review 3.  [Advances in chromatography in the study of drug-plasma protein interactions].

Authors:  Yu Bai; Yufan Fan; Guangbo Ge; Fangjun Wang
Journal:  Se Pu       Date:  2021-10

Review 4.  Clinical and pharmaceutical applications of affinity ligands in capillary electrophoresis: A review.

Authors:  Chenhua Zhang; Ashley G Woolfork; Kyungah Suh; Susan Ovbude; Cong Bi; Marawan Elzoeiry; David S Hage
Journal:  J Pharm Biomed Anal       Date:  2019-09-12       Impact factor: 3.935

Review 5.  Recent developments in protein-ligand affinity mass spectrometry.

Authors:  Niels Jonker; Jeroen Kool; Hubertus Irth; Wilfried M A Niessen
Journal:  Anal Bioanal Chem       Date:  2010-11-08       Impact factor: 4.142

6.  Interaction between Antibacterial Peptide Apep10 and Escherichia coli Membrane Lipids Evaluated Using Liposome as Pseudo-Stationary Phase.

Authors:  Wenting Tang; Chuanfen Pu; Man Li
Journal:  PLoS One       Date:  2017-01-04       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.